COLLEEN GRAINGER: Open Payments
NPI 1982471306 · HILLIARD, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,000 in 59 payments from 15 companies in 2025. Trend: 2023 $24 · 2024 $579 · 2025 $1,000
Food & beverage: $1,000
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 11 | $254 |
| ABBVIE INC. | 21 | $197 |
| Astellas Pharma US Inc | 7 | $146 |
| Lilly USA, LLC | 4 | $81 |
| Cranial Technologies, Inc | 3 | $49 |
| Exact Sciences Corporation | 2 | $48 |
| Xeris Pharmaceuticals, Inc. | 2 | $45 |
| Otsuka America Pharmaceutical, Inc. | 2 | $34 |
| Merck Sharp & Dohme LLC | 1 | $32 |
| PFIZER INC. | 1 | $24 |
Products named: Veozah, Ozempic, Wegovy, QULIPTA, VRAYLAR, MOUNJARO, Doc Band, Cologuard Collection Kit.
Industry payments across OH — which companies pay providers there.
